Diagnos Inc.
ADK.V
TSX
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 12.05% | -38.06% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 12.05% | -38.06% | |||
Cost of Revenue | -6.16% | 149.08% | |||
Gross Profit | 7.58% | -226.11% | |||
SG&A Expenses | 31.08% | 21.10% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 18.20% | 47.25% | |||
Operating Income | -18.36% | -52.66% | |||
Income Before Tax | -15.96% | -42.72% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -15.96% | -42.72% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -15.96% | -42.72% | |||
EBIT | -18.36% | -52.66% | |||
EBITDA | -19.07% | -55.66% | |||
EPS Basic | -1.10% | -35.82% | |||
Normalized Basic EPS | -1.75% | -35.71% | |||
EPS Diluted | -1.10% | -35.82% | |||
Normalized Diluted EPS | -1.75% | -35.71% | |||
Average Basic Shares Outstanding | 13.81% | 5.61% | |||
Average Diluted Shares Outstanding | 13.81% | 5.61% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |